Lisdexamfetamine and olanzapine increased dopamine efflux in cortex and accumbens more than either drug individually.
Lisdexamfetamine did not affect olanzapine's ability to block striatal D2 receptors.
The ability of lisdexamfetamine to generalize to a d-amphetamine cue was attenuated by olanzapine.